Zacks Investment Management Catalent, Inc. Transaction History

Zacks Investment Management

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$109.17 - $142.35 $1.91 Million - $2.49 Million	-17,502 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$100.34 - $115.69 $52,176 - $60,158	520 Added 3.06%	17,502 $1.89 Million
Q1 2021 May 17, 2021	BUY	$101.51 - $125.27 $51,161 - $63,136	504 Added 3.06%	16,982 $1.79 Million
Q4 2020 Feb 16, 2021	BUY	$85.88 - $105.36 $399,427 - $490,029	4,651 Added 39.33%	16,478 $1.72 Million
Q3 2020 Nov 16, 2020	BUY	$72.74 - $92.5 $860,295 - $1.09 Million	11,827 New	11,827 $1.01 Million
Q1 2018 May 14, 2018	SELL	$39.4 - $47.39 $1.64 Million - $1.97 Million	-41,620 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$37.27 - $43.02 $427,747 - $493,740	11,477 Added 38.08%	41,620 $1.71 Million
Q3 2017 Nov 14, 2017	BUY	$33.75 - $41.67 $1.02 Million - $1.26 Million	30,143	30,143 $1.2 Million

514

149M

575K

2.03M

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11.4B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Zacks Investment Management, based on Form 13F filings with the SEC.

Stay updated on Zacks Investment Management with notifications on news.